Conversely, established AML cells rely on EZH2 to repress differentiation-inducing or tumour-suppressive pathways, thereby preserving a leukemic stem-like state; accordingly, EZH2 inactivation downregulates AML maintenance programs without reactivating HOX loci. This evidence concerns the gene EZH2 and acute myeloid leukemia.